Evidence mapPaperPMID 39596116Full record

ArticleInternational journal of molecular sciences2024

Forced Overexpression and Knockout Analysis of SLC30A and SLC39A Family Genes Suggests Their Involvement in Establishing Resistance to Cisplatin in Human Cancer Cells.

Margarita Kamynina, Julian M Rozenberg, Artem S Kushchenko, Sergey E Dmitriev, Aleksander Modestov, Dmitry Kamashev, Nurshat Gaifullin, Nina Shaban, Maria Suntsova, Anna Emelianova and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Margarita KamyninaWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0001-8093-8151
Julian M RozenbergEndocrinology Research Center, Ulyanova St. 11, 117036 Moscow, Russia.ORCID 0000-0002-7627-5217
Artem S KushchenkoBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
Sergey E DmitrievBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-1774-8475
Aleksander ModestovWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0002-1531-7161
Dmitry KamashevWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Nurshat GaifullinFaculty of Fundamental Medicine, Moscow State University, 119992 Moscow, Russia.
Nina ShabanWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0002-7632-4883
Maria SuntsovaWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Anna EmelianovaWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Anton A BuzdinWorld-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2022-304Russian Science Foundation No. 23-14-00218
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cation Transport ProteinsCisplatinDrug Resistance, NeoplasmAntineoplastic AgentsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGene Knockout TechniquesHumansNeoplasmsZincAntineoplastic AgentsCation Transport ProteinsCisplatinSLC39A14 protein, humanZinccancercetuximabcisplatinintracellular signaling pathwaysmanganesemitochondrial respirationSLC30A10SLC30A3SLC39A14SLC39A8zinc

Identifiers

PMID39596116
PMCPMC11594112

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.